U.S. Markets closed
LISTEN

Schultz: Businesses need to do more to help people

Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz

VanEck Vectors Biotech ETF (BBH)

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Add to watchlist
133.57-0.06 (-0.04%)
At close: 3:59PM EDT
People also watch
PPHHHHTTHBHHIAH
Full screen
Previous Close133.63
Open133.05
Bid132.79 x 600
Ask135.98 x 600
Day's Range132.73 - 133.65
52 Week Range99.60 - 136.83
Volume8,371
Avg. Volume26,157
Net Assets716.33M
NAV135.25
PE Ratio (TTM)N/A
Yield0.24%
YTD Return25.71%
Beta (3y)1.28
Expense Ratio (net)0.35%
Inception Date2011-12-20
Trade prices are not sourced from all markets
  • Market Realist4 days ago

    Benefitting from IBB’s Lower Expense Ratio

    The iShares NASDAQ Biotechnology ETF (IBB) is an open-end fund with assets under management of $9.85 billion.

  • Market Realist11 days ago

    How Gilead’s HIV and HBV Portfolios Performed in 2Q17

    Gilead Sciences' (GILD) portfolio includes various drugs for key therapeutic areas including HIV/AIDS, liver diseases, oncology, cardiovascular, inflammation, respiratory, and others.

  • Barrons.com17 days ago

    The Summer Of Biotech Isn't Over Yet

    The biotech sector has been on fire this summer, but the good times aren’t all behind us. Cann writes that using a relative Price-to-earnings-growth ratio, the biotech sector is still almost a full deviation below a sell-signal level. The biotech group relative P/E had generally been contracting from 2015 to the end of May 2017.